Helius Medical Systems (NASDAQ:HSDT – Get Score) was downgraded by Zacks Financial commitment Investigation from a “buy” score to a “hold” score in a investigation take note issued on Friday, Zacks.com reports.
According to Zacks, “Helius Professional medical Technologies Inc. is a specialty medical machine company. It is concentrated on the improvement and regulatory approval of its non-invasive neurostimulation device known as PoNS. The Firm is nearing scientific trials for stability problems in TBI people and for the remedy of MS. Helius Health-related Systems, Inc. is based mostly in Newtown, Pennsylvania. “
Helius Healthcare Technologies inventory traded down $.04 for the duration of investing several hours on Friday, hitting $1.44. The business experienced a investing volume of 25,224 shares, in contrast to its ordinary quantity of 20,472. The organization has a market cap of $5.47 million, a PE ratio of -.20 and a beta of .82. Helius Healthcare Technologies has a just one yr low of $1.31 and a a person calendar year substantial of $17.26. The business has a 50-working day transferring ordinary of $2.81 and a 200 day relocating normal of $4.62.
Helius Health-related Technologies (NASDAQ:HSDT – Get Ranking) final announced its earnings benefits on Thursday, May perhaps 12th. The organization documented ($1.15) EPS for the quarter, lacking the consensus estimate of ($1.13) by ($.02). Helius Medical Systems experienced a detrimental return on fairness of 240.53% and a unfavorable net margin of 3,043.95%. All through the exact same quarter in the prior 12 months, the organization gained ($1.65) EPS. Equities analysts expect that Helius Health-related Systems will publish -4.18 earnings for every share for the present-day yr.
Institutional investors and hedge funds have lately designed variations to their positions in the organization. Altium Money Administration LP acquired a new placement in shares of Helius Health-related Technologies all through the fourth quarter value about $254,000. ACT Money L.L.C. improved its stake in Helius Health care Systems by 19.3% in the 3rd quarter. ACT Cash L.L.C. now owns 70,616 shares of the company’s stock valued at $1,017,000 right after attaining an additional 11,430 shares for the duration of the past quarter. Kepos Funds LP amplified its stake in Helius Healthcare Systems by 296.4% in the fourth quarter. Kepos Cash LP now owns 100,304 shares of the company’s stock valued at $521,000 just after obtaining an further 75,000 shares for the duration of the past quarter. At last, AIGH Funds Administration LLC purchased a new place in Helius Health-related Technologies in the fourth quarter valued at about $1,298,000. 29.74% of the stock is at this time owned by institutional investors.
Helius Health care Systems Company Profile (Get Rating)
Helius Professional medical Technologies, Inc, a neurotechnology company, focuses on acquiring, licensing, and acquiring non-invasive technologies for the procedure of indications prompted by neurological disorder or trauma. Its item, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical gadget intended for use as a brief phrase treatment of gait deficit because of to signs from a number of sclerosis and equilibrium deficit owing to moderate-to-reasonable traumatic brain injuries, as properly as to be employed in conjunction with supervised therapeutic work out.
See Also
For far more details about analysis offerings from Zacks Financial investment Analysis, go to Zacks.com
Want Much more Excellent Investing Ideas?
Receive News & Ratings for Helius Professional medical Systems Each day – Enter your e-mail handle beneath to obtain a concise each day summary of the newest information and analysts’ ratings for Helius Health care Systems and linked providers with MarketBeat.com’s Cost-free each day email newsletter.